{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:14:50Z","timestamp":1783440890426,"version":"3.54.6"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Leukemia Foundation of Australia"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.exphem.2025.104842","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T18:32:26Z","timestamp":1749925946000},"page":"104842","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mer receptor expression promotes multiple myeloma disease development via a cell-extrinsic mechanism"],"prefix":"10.1016","volume":"150","author":[{"given":"Justine R.","family":"Clark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6879-1262","authenticated-orcid":false,"given":"Vasilios","family":"Panagopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline E.","family":"Noll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof M.","family":"Mrozik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0678-8276","authenticated-orcid":false,"given":"Alanah L.","family":"Bradey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter I.","family":"Croucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.W.","family":"Zannettino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Vandyke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6010-1116","authenticated-orcid":false,"given":"Duncan R.","family":"Hewett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2025.104842_bib0001","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.46","article-title":"Multiple myeloma","volume":"3","author":"Kumar","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.exphem.2025.104842_bib0002","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.exphem.2025.104842_bib0004","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cyto.2018.02.020","article-title":"Role of CXCL12 and CXCR4 in the pathogenesis of hematological malignancies","volume":"109","author":"Peled","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.exphem.2025.104842_bib0005","doi-asserted-by":"crossref","first-page":"19702","DOI":"10.1002\/jcp.28570","article-title":"Blockade of SDF-1\/CXCR4 reduces adhesion-mediated chemoresistance of multiple myeloma cells via interacting with interleukin-6","volume":"234","author":"Liu","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.exphem.2025.104842_bib0006","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1182\/blood-2010-04-279760","article-title":"Osteoclast-gene expression profiling reveals osteoclast-derived CCR2 chemokines promoting myeloma cell migration","volume":"117","author":"Moreaux","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104842_bib0007","doi-asserted-by":"crossref","first-page":"8983","DOI":"10.1038\/ncomms9983","article-title":"Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche","volume":"6","author":"Lawson","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2025.104842_bib0008","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009076","article-title":"Biology of the TAM receptors","volume":"5","author":"Lemke","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.exphem.2025.104842_bib0009","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1128\/MCB.17.8.4442","article-title":"Requirement of phosphatidylinositol 3-kinase-dependent pathway and Src for Gas6-Axl mitogenic and survival activities in NIH 3T3 fibroblasts","volume":"17","author":"Goruppi","year":"1997","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2025.104842_bib0010","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/leu.2014.236","article-title":"Role of growth arrest-specific gene 6-Mer axis in multiple myeloma","volume":"29","author":"Waizenegger","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2025.104842_bib0011","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10585-021-10093-z","article-title":"Siemann DW. Inhibition of the Axl pathway impairs breast and prostate cancer metastasis to the bones and bone remodeling","volume":"38","author":"Tanaka","year":"2021","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.exphem.2025.104842_bib0012","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1158\/1541-7786.MCR-18-0718","article-title":"AXL is a putative tumor suppressor and dormancy regulator in prostate cancer","volume":"17","author":"Axelrod","year":"2019","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.exphem.2025.104842_bib0013","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.97941","article-title":"MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity","volume":"3","author":"Lee-Sherick","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.exphem.2025.104842_bib0014","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1158\/0008-5472.CAN-20-2066","article-title":"Axl and Mertk receptors cooperate to promote breast cancer progression by combined oncogenic signaling and evasion of host antitumor immunity","volume":"81","author":"Davra","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2025.104842_bib0015","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1182\/blood-2013-03-491431","article-title":"Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine crosstalk of leukemia cells with bone marrow stroma","volume":"122","author":"Ben-Batalla","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104842_bib0016","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1158\/1541-7786.MCR-16-0350","article-title":"Phosphatidylserine sensing by TAM receptors regulates AKT-dependent chemoresistance and PD-L1 expression","volume":"15","author":"Kasikara","year":"2017","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.exphem.2025.104842_bib0017","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1158\/0008-5472.CAN-18-2614","article-title":"Pan-TAM tyrosine kinase inhibitor BMS-777607 enhances anti-PD-1 mAb efficacy in a murine model of triple-negative breast cancer","volume":"79","author":"Kasikara","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2025.104842_bib0018","doi-asserted-by":"crossref","first-page":"25737","DOI":"10.1074\/jbc.M114.570838","article-title":"Overexpression of MERTK receptor tyrosine kinase in epithelial cancer cells drives efferocytosis in a gain-of-function capacity","volume":"289","author":"Nguyen","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2025.104842_bib0019","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.3390\/cancers11111727","article-title":"AXL receptor tyrosine kinase as a therapeutic target in hematological malignancies: focus on multiple myeloma","volume":"11","author":"Yan","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.exphem.2025.104842_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107577","article-title":"MERTK in cancer therapy: targeting the receptor tyrosine kinase in tumor cells and the immune system","volume":"213","author":"Huelse","year":"2020","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.exphem.2025.104842_bib0021","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1074\/jbc.M116.733030","article-title":"Autocrine and paracrine interactions between multiple myeloma cells and bone marrow stromal cells by growth arrest-specific gene 6 cross-talk with interleukin-6","volume":"292","author":"Furukawa","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2025.104842_bib0022","doi-asserted-by":"crossref","first-page":"7689","DOI":"10.1038\/s41467-022-33938-x","article-title":"Regulation of bone homeostasis by MERTK and TYRO3","volume":"13","author":"Engelmann","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2025.104842_bib0023","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/blood.2018880930","article-title":"A niche-dependent myeloid transcriptome signature defines dormant myeloma cells","volume":"134","author":"Khoo","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.104842_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061873","article-title":"GAS6 receptor status is associated with dormancy and bone metastatic tumor formation","volume":"8","author":"Taichman","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2025.104842_bib0025","doi-asserted-by":"crossref","DOI":"10.1038\/srep36520","article-title":"Axl is required for TGF-\u03b22-induced dormancy of prostate cancer cells in the bone marrow","volume":"6","author":"Yumoto","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.exphem.2025.104842_bib0026","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.yexcr.2015.01.006","article-title":"Tetraspanin 7 (TSPAN7) expression is upregulated in multiple myeloma patients and inhibits myeloma tumour development in vivo","volume":"332","author":"Cheong","year":"2015","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.exphem.2025.104842_bib0027","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13045-015-0209-2","article-title":"PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma","volume":"8","author":"Noll","year":"2015","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.exphem.2025.104842_bib0028","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/s41375-019-0543-4","article-title":"MYC dysregulation in the progression of multiple myeloma","volume":"34","author":"Misund","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2025.104842_bib0029","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat Protoc"},{"key":"10.1016\/j.exphem.2025.104842_bib0030","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.neo.2014.07.002","article-title":"SAMSN1 is a tumor suppressor gene in multiple myeloma","volume":"16","author":"Noll","year":"2014","journal-title":"Neoplasia"},{"key":"10.1016\/j.exphem.2025.104842_bib0031","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.exphem.2025.104842_bib0032","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/978-1-4939-7371-2_3","article-title":"Flow cytometric detection of G0 in live cells by Hoechst 33342 and pyronin Y staining","volume":"1686","author":"Eddaoudi","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.exphem.2025.104842_bib0033","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41568-020-0263-0","article-title":"The dormant cancer cell life cycle","volume":"20","author":"Phan","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2025.104842_bib0034","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","article-title":"Regulatory mechanisms of PD-1\/PD-L1 in cancers","volume":"23","author":"Lin","year":"2024","journal-title":"Mol Cancer"},{"key":"10.1016\/j.exphem.2025.104842_bib0035","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1158\/0008-5472.CAN-17-0236","article-title":"Expansion of tumor-infiltrating CD8+ T cells expressing PD-1 improves the efficacy of adoptive T-cell therapy","volume":"77","author":"Fernandez-Poma","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2025.104842_bib0036","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-008979","article-title":"Depletion of myeloid-derived suppressor cells sensitizes murine multiple myeloma to PD-1 checkpoint inhibitors","volume":"13","author":"Xiong","year":"2025","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.exphem.2025.104842_bib0037","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.4049\/jimmunol.174.10.6477","article-title":"Human lymphoid and myeloid cell development in NOD\/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells","volume":"174","author":"Shultz","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2025.104842_bib0038","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1132","article-title":"Identification of the immune checkpoint signature of multiple myeloma using mass cytometry-based single-cell analysis","volume":"9","author":"Wang","year":"2020","journal-title":"Clin Transl Immunology"},{"key":"10.1016\/j.exphem.2025.104842_bib0039","article-title":"Standardisation of minimal residual disease in multiple myeloma","volume":"26","author":"Innao","year":"2017","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.exphem.2025.104842_bib0040","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.3390\/jcm10122648","article-title":"Prostate cancer dormancy and reactivation in bone marrow","volume":"10","author":"Singh","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.exphem.2025.104842_bib0041","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1021\/jm801586s","article-title":"Discovery of N-(4-(2-Amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a selective and orally efficacious inhibitor of the Met kinase superfamily","volume":"52","author":"Schroeder","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.exphem.2025.104842_bib0042","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1158\/1535-7163.MCT-13-0242","article-title":"Synergistic activities of MET\/RON inhibitor BMS-777607 and mTOR inhibitor AZD8055 to polyploid cells derived from pancreatic cancer and cancer stem cells","volume":"13","author":"Zeng","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.exphem.2025.104842_bib0043","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1038\/s41375-019-0561-2","article-title":"Relapsed refractory multiple myeloma: a comprehensive overview","volume":"33","author":"Bazarbachi","year":"2019","journal-title":"Leukemia"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X2500133X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X2500133X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:17:24Z","timestamp":1783437444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X2500133X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":42,"alternative-id":["S0301472X2500133X"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2025.104842","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mer receptor expression promotes multiple myeloma disease development via a cell-extrinsic mechanism","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2025.104842","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of International Society for Experimental Hematology.","name":"copyright","label":"Copyright"}],"article-number":"104842"}}